← Back to the biomarker database

Amlodipin: the pathway in the body

Amlodipin is part of the pathway “Amlodipine”. This page shows the whole pathway; the station of Amlodipin is highlighted.

Where this laboratory value sits: Amlodipine — tablet, swallowed. Amlodipine is swallowed as a tablet. It belongs to the dihydropyridines and is already the form that acts at the channel; nothing has to be cleaved off first in the body. It inhibits calcium inflow into vessel muscle. Source 8

In brief

Amlodipine is a dihydropyridine. It settles into a niche of the voltage-gated calcium channel of the L-type and lets less calcium flow into the vessel muscle cell. The channel is a door, not a store. The vessel muscle thus relaxes, and the vessel widens.

What this is about

The smooth muscle of the vessel wall tightens over a short chain of steps:

Amlodipine settles into a niche of the L-type channel and lets less calcium through. The rise inside the cell therefore turns out smaller, and the step across calcium-calmodulin is set off less often. This changes nothing about the body's stock of calcium: the prescribing information states expressly that serum calcium is unaffected by amlodipine. The channel is a door, not a store.

What this means in an individual case depends on many things and belongs in a conversation with a doctor or health practitioner.

Source 2, 3, 4, 5, 6, 8

12 stations · 9 sources
ORYPath of the substanceInside the muscle cellIP3 receptorvoltage sensorL-type channelcalmodulinMLCKMg-ATPsettles into the nichelets less calcium throughremoves phosphateAmlodipinetablet, swallowedSlow absorptionpeak only after hoursCharged in the bodybinds and comes off slowlyEliminationconverted in the liverNiche at the channelto the side, not in the poreVoltage at the cell wallset by potassium channelsL-type channeldoor for calcium outsideCalcium in the cella short rise as a signalCalcium-calmodulinpair of ion and proteinPhosphate on myosinthe light chain of myosinStore inside the cellendoplasmic reticulumMyosin phosphatasecounterpart of the kinase

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Amlodipine → Slow absorption The substance is absorbed slowly. The label puts the peak in the blood several hours after swallowing and notes that food does not change the amount absorbed. The amount in the blood thus rises gradually. Source 8↑ supplies Absorption in the gut brings the active substance into the blood. Because this happens slowly, the amount in the blood rises over hours, and the substance arrives at the channel gradually. established physiology Source 8
    ⚖ When the balance tips

    too much — If more active substance enters the blood than the liver breaks down in the same time, the amount in the blood keeps rising over days until inflow and breakdown balance.

    too little — If little active substance enters the blood, the amount there stays low, and correspondingly little amlodipine is present at the channel.

    established physiology · Source 8

  2. Slow absorption → Charged in the body At the pH that prevails in the body, amlodipine carries a charge. It settles onto the channel only gradually and comes off just as gradually; the action therefore sets in slowly. The widening of the vessels thus lasts evenly. Source 8↑ supplies The charged form binds to the channel slowly and stays there for a long time. This produces not a sudden widening of the vessels but an even one that lasts through the day. established physiology Source 8, 3
    ⚖ When the balance tips

    too much — If a lot of bound amlodipine is present, it comes off only gradually because binding is slow; the widening of the vessels then persists even after the blood level falls.

    too little — If little is bound, this too has an effect only gradually because of the slow kinetics: the channels become free again step by step.

    established physiology · Source 8

  3. Charged in the body → Elimination The liver converts the greater part into inactive breakdown products. These leave the body mostly in the urine. The conversion is slow; amlodipine stays in the body for a long time. Source 8↓ depletes The liver removes the active substance from the blood by converting it into inactive breakdown products. This conversion is slow, which is why amlodipine stays in the body for a long time. established physiology Source 8
    ⚖ When the balance tips

    too much — If the liver breaks it down briskly, the amount in the blood falls faster, and less active substance is present at the channel.

    too little — If the liver works more slowly, for example with reduced liver function or in older age, amlodipine stays longer in the blood, and its amount there is higher.

    established physiology · Source 8

  4. Voltage at the cell wall → L-type channel · voltage sensor The voltage-gated calcium channel of the L-type opens. In the smooth muscle of the vessel wall it is the main route by which calcium comes into the cell from outside. Much inflow narrows the vessel, little inflow widens it. Source 2, 8↑ supplies The open L-type channel lets calcium into the vessel muscle cell from outside. This inflow is the signal that makes the muscle cell contract. established physiology Source 2
    ⚖ When the balance tips

    too much — If many channels are open, a lot of calcium flows in; the muscle cell contracts more strongly, and the vessel becomes narrower.

    too little — If few channels are open, little calcium enters the cell from outside; the muscle cell relaxes, and the vessel widens.

    established physiology · Source 2, 6

  5. L-type channel → Calcium in the cell L-type channel The inflowing calcium makes the amount of free calcium inside the cell rise. It is this rise alone that is read; at rest the cell holds the amount very low. Pumps quickly move it out again. Source 6, 2↕ both, depending on amount A brief rise in free calcium is the signal for contraction. If calcium stays high for long, it also switches on processes in the cell that strain it; the cell therefore pumps it out again quickly. established physiology Source 6
    ⚖ When the balance tips

    too much — If a lot of free calcium remains inside the cell, pumps and exchangers run at full speed and use up ATP; at the same time the muscle cell stays tense.

    too little — If free calcium hardly rises, little binds to calmodulin, the kinase stays idle, and the muscle cell remains relaxed.

    established physiology · Source 6

  6. Calcium in the cell → Calcium-calmodulin · calmodulin Calcium binds to calmodulin, a small protein. The loaded calmodulin changes its shape and can now dock onto myosin light chain kinase. The calcium rise thus becomes enzyme activity. Source 6, 5↑ supplies Loaded calmodulin switches on myosin light chain kinase. It translates the rise in calcium into enzyme activity. established physiology Source 6, 5
    ⚖ When the balance tips

    too much — If a lot of calcium-calmodulin is present, the kinase is fully active, and the light chain of myosin is loaded with phosphate quickly.

    too little — If little calcium-calmodulin is present, the kinase stays largely switched off, and the phosphatase wins the contest.

    established physiology · Source 5

  7. Calcium-calmodulin → Phosphate on myosin MLCK · Mg-ATP Only with calcium-calmodulin bound does myosin light chain kinase work. It transfers phosphate from Mg-ATP onto the light chain of myosin; after that, myosin and actin engage with each other. The vessel wall tenses. Source 5, 4↑ supplies With phosphate on the light chain, myosin and actin engage; the muscle cell contracts, and the vessel wall tenses. On this depends how wide the vessel is. established physiology Source 4, 5
    ⚖ When the balance tips

    too much — If a lot of myosin is loaded with phosphate, the vessel muscle stays tense, the vessel narrow and the resistance in the circulation high.

    too little — If little myosin is loaded with phosphate, myosin and actin separate, the vessel muscle relaxes, and the vessel widens.

    established physiology · Source 4

  8. Store inside the cell → Calcium in the cell IP3 receptor The inflowing calcium makes the amount of free calcium inside the cell rise. It is this rise alone that is read; at rest the cell holds the amount very low. Pumps quickly move it out again. Source 6, 2↕ both, depending on amount A brief rise in free calcium is the signal for contraction. If calcium stays high for long, it also switches on processes in the cell that strain it; the cell therefore pumps it out again quickly. established physiology Source 6
    ⚖ When the balance tips

    too much — If a lot of free calcium remains inside the cell, pumps and exchangers run at full speed and use up ATP; at the same time the muscle cell stays tense.

    too little — If free calcium hardly rises, little binds to calmodulin, the kinase stays idle, and the muscle cell remains relaxed.

    established physiology · Source 6

Further stations

What depends on the calcium influx

What takes part in these steps

What the prescribing information states

Controlled trials in the United States in which amlodipine was compared directly against placebo. The prescribing information sorts these four reactions by the amount of the substance: steps 1 to 3 are the three amounts studied, from the smallest to the largest. The figures apply to these trials.

How to read the table: each row carries four figures, and only the comparison says something. For fluid retention the gap to placebo grows markedly with the amount of the substance; for dizziness it stays small. There is no column with another medicine here — this prescribing information compares against placebo alone. And for this table it selected only reactions that were more frequent on amlodipine.

Amlodipine, step 1 (275)Amlodipine, step 2 (296)Amlodipine, step 3 (268)Placebo (520)
Fluid retention1.8%3.0%10.8%0.6%
Dizziness1.1%3.4%3.4%1.5%
Flushing of the face0.7%1.4%2.6%0.0%
Palpitation0.7%1.4%4.5%0.6%

Four further reactions are named without a link to the amount; they come from all placebo-controlled trials together, 1,730 adults on amlodipine against 1,250 on placebo: fatigue 4.5 against 2.8 of 100, nausea 2.9 against 1.9, abdominal pain 1.6 against 0.3, sleepiness 1.4 against 0.6. Reactions reported after approval are not listed here — the prescribing information notes that neither a frequency nor a causal relationship can be derived from them.

Sources

  1. Catterall WA, Swanson TM. Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels. Annu Rev Pharmacol Toxicol 2020 · PubMed 31537174
  2. Zamponi GW, Striessnig J, Koschak A et al. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev 2015 · PubMed 26362469
  3. Zhao Y, Huang G, Wu J et al. Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+ Channel. Cell 2019 · PubMed 31150622
  4. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003 · PubMed 14506307
  5. Ran Q, Tian H, Lin J et al. Action and therapeutic targets of myosin light chain kinase, an important cardiovascular signaling mechanism. Pharmacol Res 2024 · PubMed 38944220
  6. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003 · PubMed 12838335
  7. Jackson WF. Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth. Adv Pharmacol 2017 · PubMed 28212804
  8. US prescribing information (United States): Amlodipine Besylate Tablets, DailyMed, version of 17 Sept 2026, sections 12.1 Mechanism of Action, 12.2 Pharmacodynamics and 12.3 Pharmacokinetics · Prescribing information
  9. US prescribing information (United States): Amlodipine Besylate Tablets, DailyMed, version of 17 Sept 2026, sections 6.1 Clinical Trials Experience and 6.2 Postmarketing Experience · Prescribing information

Whole pathway: Amlodipine

Related pathways

As of 2026-09-25. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers